You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Diffuse Cerebral Sclerosis of Schilder

Showing 1 - 25 of 9,589
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alpers Huttenlocher Natural History Study

Terminated
  • Alpers Huttenlocher Syndrome
    • New York, New York
    • +1 more
    Jul 28, 2022

    Efficacy of Tofacitinib in the Systemic Sclerosis Trial in Dhaka (Tofacitinib)

    Recruiting
    • Efficacy of Tofacitinib in the Systemic Sclerosis
    • Dhaka, Shahbag, Bangladesh
      Nabil Amin Khan
    Sep 18, 2023

    Systemic Sclerosis, Scleroderma Trial in Worldwide (Anifrolumab (blinded), Placebo (blinded), Anifrolumab (unblinded, open

    Not yet recruiting
    • Systemic Sclerosis
    • Scleroderma
    • Anifrolumab (blinded)
    • +2 more
    • Birmingham, Alabama
    • +130 more
    Jun 22, 2023

    Diffuse Infiltrating Pneumonia Associated With Systemic

    Recruiting
    • Systemic Sclerosis
    • lung function tests
    • Lille, France
    • +1 more
    Jan 17, 2023

    Sclerosis, Multiple, MS (Multiple Sclerosis), Spastic Trial in Abu Dhabi (EXOPULSE Mollii Suit Stimulation)

    Recruiting
    • Sclerosis, Multiple
    • +4 more
    • EXOPULSE Mollii Suit Stimulation
    • Abu Dhabi, United Arab Emirates
      SSMC
    Jun 12, 2023

    Stroke Trial in Philadelphia (Nitric Oxide)

    Active, not recruiting
    • Stroke
    • Nitric Oxide
    • Philadelphia, Pennsylvania
      Hospital of the University of Pennsylvania
    Nov 23, 2022

    Diffuse Cutaneous Systemic Sclerosis Trial in United States (Belumosudil)

    Completed
    • Diffuse Cutaneous Systemic Sclerosis
    • Los Angeles, California
    • +4 more
    Jan 5, 2023

    Multiple Sclerosis, Primary Progressive Trial in Bordeaux, Limoges, Poitiers (Clinical assessment, Ecological evaluation,

    Recruiting
    • Multiple Sclerosis, Primary Progressive
    • Clinical assessment
    • +4 more
    • Bordeaux, France
    • +2 more
    Mar 31, 2022

    Stem Cell Factor,Potential Biological Marker of Skin Involvement

    Recruiting
    • Systemic Sclerosis
    • ELISA
    • Videocapillaroscopy
    • Brussels, Belgium
      CHU Brugmann
    Jul 29, 2022

    Systemic Sclerosis Trial (RY_SW01 cell injection, Basic treatment)

    Not yet recruiting
    • Systemic Sclerosis
    • RY_SW01 cell injection
    • Basic treatment
    • (no location specified)
    Sep 21, 2023

    Evaluation of Muscle Involvement in Systemic Sclerosis

    Not yet recruiting
    • Systemic Sclerosis
    • muscle involvement
    • Nancy, France
      Paul Decker
    Sep 21, 2023

    Role of Functional Neurosurgery in Management of Spasticity

    Not yet recruiting
    • Functional Neurological Disorder
    • Intrathecal balofen pump
    • (no location specified)
    Feb 7, 2023

    Diffuse Cutaneous Systemic Sclerosis Trial (Brentuximab vedotin)

    Not yet recruiting
    • Diffuse Cutaneous Systemic Sclerosis
    • Brentuximab vedotin
    • (no location specified)
    Apr 11, 2022

    An Optical Neuro-monitor of Cerebral Oxygen Metabolism and Blood

    Active, not recruiting
    • Hemodynamic Instability
    • BabyLux Neuro-monitor
    • Copenhagen, Denmark
    • +1 more
    Apr 26, 2022

    Diffuse Cutaneous Systemic Sclerosis Trial in Ann Arbor (FCR001)

    Recruiting
    • Diffuse Cutaneous Systemic Sclerosis
    • FCR001
    • Ann Arbor, Michigan
      University of Michigan
    Mar 4, 2022

    Differentiation Between Healthy Cerebral Tissue and Tumor Tissue

    Active, not recruiting
    • Glioblastoma
    • Surgical Margin
    • Diffuse Reflectance Spectroscopy
    • Stockholm, Sweden
      Karolinska University Hospital
    Dec 11, 2021

    Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic Trial in New Orleans (HZN-825)

    Recruiting
    • Diffuse Cutaneous Systemic Sclerosis
    • Sclerosis, Systemic
    • New Orleans, Louisiana
      DelRicht Clinical Research, LLC
    Nov 15, 2022

    Diffuse Cutaneous Systemic Sclerosis Trial in United States (TEPEZZA, Placebo)

    Recruiting
    • Diffuse Cutaneous Systemic Sclerosis
    • TEPEZZA
    • Placebo
    • Los Angeles, California
    • +6 more
    Jul 22, 2022

    Diffuse Cutaneous Systemic Sclerosis Trial in London (Brentuximab Vedotin)

    Recruiting
    • Diffuse Cutaneous Systemic Sclerosis
    • Brentuximab Vedotin
    • London, Ontario, Canada
      Rheumatology Clinic, St. Joseph's Health Care
    Feb 3, 2022

    Subarachnoid Hemorrhage, Aneurysmal Trial (Shuxuening injection or )

    Not yet recruiting
    • Subarachnoid Hemorrhage, Aneurysmal
    • Shuxuening injection or placebo
    • (no location specified)
    Nov 18, 2023

    Diffuse Cutaneous Systemic Sclerosis, Scleroderma, dcSSc Trial in Canada, United States (Brentuximab Vedotin, Placebo)

    Recruiting
    • Diffuse Cutaneous Systemic Sclerosis
    • +2 more
    • Brentuximab Vedotin
    • Placebo
    • Los Angeles, California
    • +9 more
    May 12, 2022

    Multiple Sclerosis Trial in Philadelphia (N-acetyl Cysteine)

    Enrolling by invitation
    • Multiple Sclerosis
    • N-acetyl Cysteine
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Aug 26, 2022

    Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited Trial in India, United States (Oral Ifetroban, Oral Placebo)

    Recruiting
    • Scleroderma, Diffuse
    • +7 more
    • Oral Ifetroban
    • Oral Placebo
    • Tucson, Arizona
    • +15 more
    Jun 30, 2022

    NIRS Monitoring in Premature Infants

    Recruiting
    • Hemorrhage
    • +3 more
    • ETV/CPC
    • Boston, Massachusetts
    • +2 more
    Jul 28, 2022

    Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Intrinsic Pontine Glioma, Diffuse Glioma Trial (Re-irradiation)

    Not yet recruiting
    • Diffuse Midline Glioma, H3 K27M-Mutant
    • +5 more
    • Re-irradiation
    • (no location specified)
    Oct 16, 2023